Literature DB >> 24403869

Generalized Redistribute-to-the-Right Algorithm: Application to the Analysis of Censored Cost Data.

Shuai Chen1, Hongwei Zhao2.   

Abstract

Medical cost estimation is a challenging task when censoring of data is present. Although researchers have proposed methods for estimating mean costs, these are often derived from theory and are not always easy to understand. We provide an alternative method, based on a replace-from-the-right algorithm, for estimating mean costs more efficiently. We show that our estimator is equivalent to an existing one that is based on the inverse probability weighting principle and semiparametric efficiency theory. We also propose an alternative method for estimating the survival function of costs, based on the redistribute-to-the-right algorithm, that was originally used for explaining the Kaplan-Meier estimator. We show that this second proposed estimator is equivalent to a simple weighted survival estimator of costs. Finally, we develop a more efficient survival estimator of costs, using the same redistribute-to-the-right principle. This estimator is naturally monotone, more efficient than some existing survival estimators, and has a quite small bias in many realistic settings. We conduct numerical studies to examine the finite sample property of the survival estimators for costs, and show that our new estimator has small mean squared errors when the sample size is not too large. We apply both existing and new estimators to a data example from a randomized cardiovascular clinical trial.

Entities:  

Keywords:  Mean cost; Median cost; Redistribute-to-the-right; Replace-from-the-right; Survival analysis; Survival estimator for costs

Year:  2013        PMID: 24403869      PMCID: PMC3882135          DOI: 10.1080/15598608.2013.771556

Source DB:  PubMed          Journal:  J Stat Theory Pract        ISSN: 1559-8608


  10 in total

1.  On estimating medical cost and incremental cost-effectiveness ratios with censored data.

Authors:  H Zhao; L Tian
Journal:  Biometrics       Date:  2001-12       Impact factor: 2.571

2.  Regression analysis of incomplete medical cost data.

Authors:  D Y Lin
Journal:  Stat Med       Date:  2003-04-15       Impact factor: 2.373

3.  Median regression with censored cost data.

Authors:  Heejung Bang; Anastasios A Tsiatis
Journal:  Biometrics       Date:  2002-09       Impact factor: 2.571

4.  The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.

Authors:  Jack Zwanziger; W Jackson Hall; Andrew W Dick; Hongwei Zhao; Alvin I Mushlin; Rebecca Marron Hahn; Hongkun Wang; Mark L Andrews; Cathleen Mooney; Hongyue Wang; Arthur J Moss
Journal:  J Am Coll Cardiol       Date:  2006-05-04       Impact factor: 24.094

5.  On the equivalence of some medical cost estimators with censored data.

Authors:  Hongwei Zhao; Heejung Bang; Hongkun Wang; Phillip E Pfeifer
Journal:  Stat Med       Date:  2007-10-30       Impact factor: 2.373

6.  Estimating medical costs from incomplete follow-up data.

Authors:  D Y Lin; E J Feuer; R Etzioni; Y Wax
Journal:  Biometrics       Date:  1997-06       Impact factor: 2.571

7.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

8.  Nonparametric inference for median costs with censored data.

Authors:  Hongwei Zhao; Chen Zuo; Shuai Chen; Heejung Bang
Journal:  Biometrics       Date:  2012-02-24       Impact factor: 2.571

9.  The Kaplan-Meier Estimator as an Inverse-Probability-of-Censoring Weighted Average.

Authors:  Glen A Satten; Somnath Datta
Journal:  Am Stat       Date:  2012-01-01       Impact factor: 8.710

10.  Some insight on censored cost estimators.

Authors:  H Zhao; Y Cheng; H Bang
Journal:  Stat Med       Date:  2011-07-11       Impact factor: 2.373

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.